ICU — SeaStar Medical Holding Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1831868 ·
Last close
$0.78
Market Cap
$4.15M
52W High
$5.38
52W Low
$0.78
ADV30
291,658
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 615,000 | 561,000 | -3,791,000 | -3,730,000 | 8,649,000 | 6,959,000 | 4,353,000 |
| Mar 2026 | 495,000 | 449,000 | -3,603,000 | -3,521,000 | 11,263,000 | 9,348,000 | 3,948,000 |
| Dec 2025 | 420,000 | 408,000 | -3,016,000 | -2,904,000 | 14,158,000 | 11,980,000 | 3,742,000 |
| Sep 2025 | 183,000 | 169,000 | -3,579,000 | -3,472,000 | 15,530,000 | 13,763,000 | 4,066,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-13,693,000
Investing CF
—
Financing CF
$14,350,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.91
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-158,965,000
Inventory
$77,000
Receivables
$208,000
ST Investments
—
EBIT TTM
$-13,597,000
Pretax Income TTM
$-13,624,000
Interest Exp TTM
$27,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,713,000
EBITDA
—
Free Cash Flow
$-9,141,000
Enterprise Value
$-2,197,817
Total Cash
$6,959,000
Total Debt
$134,000
Shares Out
5,315,967
Trailing EPS
$-2.97
Book Value
$2.71
ROE
-356.9%
ROA
-102.7%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,234,000 | -12,175,000 | -12,150,000 | 14,158,000 | 3,742,000 | 10,416,000 | -13,599,000 |
| Dec 2024 | 135,000 | -17,842,000 | -24,830,000 | 4,658,000 | 6,841,000 | -2,183,000 | -16,007,000 |
| Dec 2023 | 0 | -14,210,000 | -26,232,000 | 3,513,000 | 17,383,000 | -13,870,000 | -10,285,000 |
| Dec 2022 | 0 | -11,609,000 | -12,190,000 | 3,038,000 | 23,800,000 | -20,762,000 | -7,794,000 |
TTM Snapshot
Revenues TTM
$1,713,000
NetIncome TTM
$-13,627,000
OpCashFlow TTM
—
Assets (Latest)
$8,649,000
Forward EPS
$-2.57
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TUTH | Standard Dental Labs Inc. | $4.10M | $0.13 | — |
| SNOA | Sonoma Pharmaceuticals, Inc. | $4.22M | $0.83 | — |
| NVNO | enVVeno Medical Corp | $4.01M | $5.77 | — |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | $4.71M | $5.50 | — |
| OSRH | OSR Health, Inc. | $3.51M | $0.10 | — |
News headlines (Yahoo Finance, 1h cache)
ICU: QUELIMMUNE® Commercial Adoption Continues; Adult AKI Study Progresses Toward 2027 Completion
2026-11-16 10:38 · Yahoo
SeaStar Medical Holding Corporation Q3 2026 Earnings Call Summary
2026-11-13 01:55 · Yahoo
SeaStar Medical Holding Corp (ICU) (Q3 2026) Earnings Call Highlights: Qualimmune Revenue Jumps ...
2026-11-12 05:06 · Yahoo
SeaStar Medical (ICU) Q3 2026 Earnings Call Transcript
2026-11-12 02:28 · Yahoo
SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates
2026-11-11 21:05 · Yahoo
SeaStar Medical to Report Third Quarter Financial Results on November 11, 2026
2026-11-04 13:41 · Yahoo
FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients
2026-11-03 13:21 · Yahoo
ICU: QUELIMMUNE® Demonstrates Statistically Significant Survival Benefit in SAVE Registry Patients
2026-10-23 11:11 · Yahoo
SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI
2026-10-22 16:01 · Yahoo
SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award
2026-10-14 12:37 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.